2 enrolling by invitation. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Enrolling by invitation 2 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Peripheral Nervous System Neoplasms: new trials by email Literature Review of Peripheral Nervous System Neoplasms trials Research Report on Peripheral Nervous System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA BNCT, ［18F］FBPA - Thoracic Solid Malignant Tumor | Phase 1 / Phase 2 | Enrolling by invitation | Stella Pharma Corporation | 30 | 2025-04-10 | 2025-11-19 |
| Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) Kybella - Neurofibromas, Cutaneous, Neurofibromatosis 1 | Phase 1 | Enrolling by invitation | Massachusetts General Hospital | 15 | 2025-04-08 | 2026-04-22 |
Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Mesothelioma, Malignant (1) · Neurofibroma (1) · Neurofibromatosis 1 (1) · Neurofibrosarcoma (1)
Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Nerve Tissue (2) · Nerve Sheath Neoplasms (2) · Nervous System Diseases (2) · Nervous System Neoplasms (2) · Neuromuscular Diseases (2) · Peripheral Nervous System Diseases (2) · Adenoma (1) · Breast Diseases (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Diseases (1)
Deoxycholic Acid (1)
Massachusetts General Hospital (1) · Stella Pharma Corporation (1)
Japan (1) · United States (1)